COVID-19: Production capacity of Remdesivir increased to nearly 119 lakh vials per month, says Govt ANI | Updated: May 17, 2021 17:33 IST
New Delhi [India], May 17 (ANI): With the sudden increase of cases during the second wave of the pandemic, the government has taken swift actions to enhance the availability of an anti-viral drug Remdesivir across the country. Presently, nearly 119 lakh vials of Remdesivir are being produced per month, the Department of Pharmaceuticals informed on Monday.
The department has, ever since, intensified the monitor on the availability, production and supply of Remdesivir. This has resulted in a substantial increase in the number of manufacturing sites of Remdesivir.
Black fungus: Supply of key drug to be ramped up for mucormycosis treatment
The government said that it is engaging with manufacturers to ramp up production of the drug. Supply of Amphotericin B will be improved through an increase in production and extra imports
BusinessToday.In | May 12, 2021 | Updated 15:31 IST
Centre to ramp up Amphotericin B supply for mucormycosis or black fungus treatment
The Centre has decided to ramp up supply of Amphotericin B in some states as healthcare workers now fight another threat mucormycosis or black fungus. The increase in supply comes as some states are demanding the drug as it has been actively prescribed by physicians to treat the post-COVID complication.
Govt takes steps to make available drug to fight black fungus
By IANS |
3 Views
Govt takes steps to make available drug to fight black fungus. Image Source: IANS News
New Delhi, May 12 : The government has said it is taking steps to ramp up availability of Amphotericin B - to fight Mucormycosis, a black fungus infection in Covid patients.
The sudden increase in demand has been observed in some states for Amphotericin B which is being actively prescribed by the physicians to patients suffering from Mucormycosis, a post Covid complication, said the Chemical and Fertilizer Ministry.
Doctors have raised an alarm about Mucormycosis, also known as black fungus, which can turn dangerous if left untreated, amid reports of re-emergence of the rare deadly fungal infection among Covid-19 patients across hospitals in Delhi, Pune and Ahmedabad.
Synopsis
With a spike in the cases of COVID-19 in the country, doctors have been reporting a rare infection mucormycosis, also called as black fungus, among people recovered from COVID-19. The infection is caused by exposure to mucor mould and it affects the sinuses, the brain and the lungs and can be life-threatening.
Agencies
The government is engaging with the drug manufacturers to ramp up the production of an antifungal drug used for the treatment of mucormycosis, the Chemicals and Fertilizers Ministry said, as a rash of cases of rare black fungus infection have been reported among people either recovered or recovering from COVID-19.
Read more about Govt ramps up availability of Amphotericin B to fight Covid complication on Business Standard. Amid a sudden increase in demand observed in some states for Amphotericin B which is being prescribed by physicians to patients suffering from Mucormycosis